ClinicalTrials.gov
public full text
Public Domain
Clopidogrel Versus Cilostazol in Ischemic Stroke
Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of clopidogrel administered within 24 hours of the first-ever moderate to severe ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS#883132
- Fructose for Acute Ischemic Stroke#836813
- Randomization of Endovascular Treatment in Acute Ischemic Stroke in the Extended Time Window#909096
- Neuroprotection With Minocycline Therapy for Acute Stroke Recovery Trial#861206
- Effects of Post-Operative Sedation for Endovascular Thrombectomy#857215
Record · ID 1172288
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive